The U.S. Pharmacopeia (USP) is proposing to require cautionary statements on the labels of dietary supplements that claim to contain USP-grade black cohosh (Actaea racemosa syn. Cimicifuga racemosa) or green tea (Camellia sinensis) extract. The proposed statements are:
Caution: In rare cases black cohosh has been reported to affect the liver. Discontinue use and consult a healthcare practitioner if you have a liver disorder or develop symptoms of liver trouble, such as abdominal pain, dark urine, or jaundice.
Caution: Must take with a meal. In rare cases extracts from green tea have been reported to adversely affect the liver. Discontinue use and consult a healthcare practitioner if you have a liver disorder or develop symptoms of liver trouble, such as abdominal pain, dark urine, or jaundice.
No comments:
Post a Comment